Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk ( ARCH) trial

Author:

Brown Jacques P.1ORCID,Engelke Klaus23,Keaveny Tony M.4,Chines Arkadi5,Chapurlat Roland6ORCID,Foldes A. Joseph7,Nogues Xavier8,Civitelli Roberto9ORCID,De Villiers Tobias10,Massari Fabio11,Zerbini Cristiano A.F.12,Wang Zhenxun5,Oates Mary K.5,Recknor Christopher13,Libanati Cesar14ORCID

Affiliation:

1. Centre Hospitalier Universitaire (CHU) de Québec Research Centre, Department of Medicine, Rheumatology Division Laval University Quebec City Québec Canada

2. Bioclinica Hamburg Germany

3. Department of Medicine 3 Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) and Universitätsklinikum Erlangen Erlangen Germany

4. Departments of Mechanical Engineering and Bioengineering University of California Berkeley Berkeley California USA

5. Amgen Inc. Thousand Oaks California USA

6. Institut National de la Santé et de la Recherche Médicale (INSERM) Unités Mixtes de Recherche (UMR) 1033 Université de Lyon, Hôpital E Herriot Lyon France

7. Osteoporosis Center Hadassah Hebrew University Medical Center Jerusalem Israel

8. Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES) Autonomous University of Barcelona Barcelona Spain

9. Musculoskeletal Research Center Washington University School of Medicine St. Louis Missouri USA

10. Department of Obstetrics and Gynaecology Stellenbosch University Stellenbosch South Africa

11. Instituto de Diagnóstico e Investigaciones Metabólicas Buenos Aires Argentina

12. Centro Paulista de Investigação Clinica São Paulo Brazil

13. United Osteoporosis Centers Gainesville Georgia USA

14. UCB Pharma Brussels Belgium

Funder

Amgen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3